DeutschEnglish
Abt. II: Pharmakologie

Post-Docs pharmacology/neuroinflammation (m/f)

reference number 24/2017






The Max Planck Institute for Heart and Lung Research in Bad Nauheim nearby Frankfurt am Main is looking for a

postdoctoral researcher in the field of inflammatory diseases.

The position will be available as of February 1st, 2018.

JOB DESCRIPTION
We seek an enthusiastic, highly motivated Postdoc to join our research group working on G-protein-mediated signaling in immune cells. The project focuses on the molecular mechanisms contributing to inflammatory processes in the nervous system, with a focus on multiple sclerosis. The project will involve the generation and analysis of constitutive and conditional mouse mutants, in vitro and in vivo pharmacology, histology, molecular biology, protein biochemistry, and flow cytometry. Skills in molecular biology, cell biology and analytical FACS are required; experience with murine experimental autoimmune encephalomyelitis and cell sorting would be highly appreciated.

ABOUT THE EMPLOYER
The Max Planck Institute for Heart and Lung Research in Bad Nauheim is an interdisciplinary research institution with international flair. Our researchers have the opportunity to work on various model systems by making use of latest cutting edge technologies. The Max Planck Society wishes to increase the share of women in areas in which they are underrepresented. Women are strongly invited to apply. The Max Planck Society is committed to employing more handicapped individuals and especially encourages them to apply. Salaries will be based on previous experience according to TVöD guidelines.

YOUR APPLICATION
Applicants should send a statement of interest, a full CV including certificates, and the names and addresses of two references to the address below or by email to

Nina.Wettschureck@mpi-bn.mpg.de

Prof. Dr. Nina Wettschureck
Max Planck Institute
for Heart and Lung Research
Ludwigstraße 43
61231 Bad Nauheim, Germany

Internet: http://a2.mpi-bn.mpg.de/index.php/wettschureck-group

© 2017 Max-Planck-Institut für Herz- und Lungenforschung, Bad Nauheim